Milmed Unico AB
Early-stage developer of patented medicinal probiotics for chronic diseases.
Oversigt
- 1
- Medarbejdere
- 78t SEK
- Omsætning
- 2018
- Grundlagt
Nøglebeslutningstagere
Johan Olsson
Board Member
Anna Linton
Board Member
Thomas Lenz
CEO
Tatiana Blomqvist
Production and Lab Manager
+8 flere kontakter i Funnelfeedr
Beskrivelse
Milmed Unico AB is an early-stage biotechnology company focused on developing groundbreaking medicinal probiotics. Their core technology is based on a patented, non-toxic yeast culture that has shown positive impacts on living cells. The company holds patent protection for treatments targeting three...